CWM
DGX icon

Cordatus Wealth Management’s Quest Diagnostics DGX Stock Holding History

Cordatus Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,916
Closed -$632K – 106
2019
Q4 		$632K Sell
5,916
-1,922
-25% -$200K 0.31% 96
2019
Q3 		$839K Sell
7,838
-433
-5% -$44.5K 0.44% 77
2019
Q2 		$842K Sell
8,271
-410
-5% -$39.4K 0.49% 64
2019
Q1 		$781K Buy
+8,681
New +$752K 0.43% 74

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cordatus Wealth Management's DGX Position: Q1 2020 in Review

Cordatus Wealth Management sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 5,916 shares — an estimated $632K sold.

Cordatus Wealth Management first reported a position in DGX in Q1 2019 and held it in 4 quarters. The position peaked at $842K in Q2 2019. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Cordatus Wealth Management reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
  • Cordatus Wealth Management sold 5,916 Quest Diagnostics shares in Q1 2020, an estimated $632K.
  • Cordatus Wealth Management first reported a position in Quest Diagnostics in Q1 2019 and held it in 4 quarters.
  • Cordatus Wealth Management's Quest Diagnostics position peaked at $842K in Q2 2019.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Cordatus Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.